📰 Nasdaq Caba News
Page 2 - Nasdaq Caba News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Caba. Real-time updates on events, politics, business and more.
January 28, 2024
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) shares shot up 7.1% during trading on Thursday . The stock traded as high as $22.08 and last traded at $21.95. 216,444 shares were traded during trading, a decline of 73% from the average session volume of 788,854 shares. The stock had previously closed at $20.50. Analyst […]
January 16, 2024
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has received an average recommendation of “Buy” from the ten analysts that are covering the firm, MarketBeat reports. Ten analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued a report on the stock in the last year […]
December 18, 2023
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) saw a large increase in short interest in November. As of November 30th, there was short interest totalling 5,670,000 shares, an increase of 12.1% from the November 15th total of 5,060,000 shares. Based on an average trading volume of 1,150,000 shares, the short-interest ratio is presently 4.9 […]
December 4, 2023
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) saw a large decline in short interest in November. As of November 15th, there was short interest totalling 5,060,000 shares, a decline of 19.4% from the October 31st total of 6,280,000 shares. Based on an average trading volume of 788,600 shares, the days-to-cover ratio is presently 6.4 […]
November 29, 2023
William Blair assumed coverage on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report issued on Wednesday, Briefing.com reports. The firm issued an outperform rating and a $38.00 price target on the stock. Several other equities analysts also recently weighed in on CABA. Guggenheim reaffirmed a buy rating and issued a $34.00 price […]
November 22, 2023
Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) traded down 4.2% during trading on Monday . The company traded as low as $17.17 and last traded at $17.20. 167,698 shares changed hands during trading, a decline of 70% from the average session volume of 560,050 shares. The stock had previously closed at $17.96. […]
November 19, 2023
Cabaletta Bio (NASDAQ:CABA – Free Report) had its price target raised by Cantor Fitzgerald from $40.00 to $50.00 in a research report sent to investors on Wednesday, Benzinga reports. Cantor Fitzgerald currently has an overweight rating on the stock. Several other equities research analysts also recently weighed in on CABA. Stifel Nicolaus started coverage on […]
November 2, 2023
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned an average recommendation of “Buy” from the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have issued a report on the stock in the […]
October 8, 2023
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has earned a consensus recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have updated their coverage on the stock in the […]
October 6, 2023
Cabaletta Bio (NASDAQ:CABA – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $17.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 9.32% from the stock’s current price. A number of […]